|
12/03/2019 |
A Study to Evaluate Patient Preference and Satisfaction of Subcutaneous Administration of the Fixed-Dose Combination of Pertuzumab and Trastuzumab in Participants With HER2-Positive Early Breast Cancer |
ROCHE |
Registered |
|
14/02/2019 |
VALERGEN-combination of routes- Asthma-Adults-Phase II |
BIOCEN |
Registered |
|
14/01/2019 |
Melagenina Plus - Vitiligo – phase IV |
CHP |
Registered outdated |
|
14/01/2019 |
Combifer-T, Trofin and Ferrous Fumarate in iron-deficiency anemia in pregnant women. |
BIOCEN |
Registered |
|
28/12/2018 |
Nimotuzumab in Non-Small Cell Lung Cancer (NSCLC) of inoperable stage III epidermoid histology, concomitant with Chemo and Radiotherapy (CRT) |
CIM |
Registered outdated |
|
28/11/2018 |
Colilen IBS- Irritable Bowel Syndrome- adults-Phase III |
ABOCA |
Registered outdated |
|
01/11/2018 |
Effectiveness of a case management model for the comprehensive provision of health services to pluripathological patients |
FUCS |
Registered |
|
22/10/2018 |
DENIS Study |
CIGB |
Registered outdated |
|
17/10/2018 |
CIMAvax-EGF® in metastatic asymptomatic or mildly symptomatic Castration Resistant Prostate Cancer patients. Phase II-III Clinical Trial |
CIM |
Registered |
|
05/10/2018 |
Nimotuzumab cold kit for the immunodiagnosis of solid tumors |
CIM |
Registered |
|
28/09/2018 |
Topic Oleozon in patients with epidermophytosis |
CPN |
Registered outdated |
|
15/08/2018 |
Evaluation of Biomodulin T® in patients with HIV/AIDS. Phase II/III. |
BIOCEN |
Registered outdated |
|
08/08/2018 |
VSSP in metastasic renal cell carcinoma |
CIM |
Registered |
|
07/08/2018 |
AMIGOS-2 study |
CIGB |
Registered outdated |
|
07/08/2018 |
CERVICONC-II-300 study |
CIGB |
Registered outdated |
|
03/08/2018 |
CIMAvax-EGF-Platelets-Adults- Lung Cancer |
CIM |
Registered |
|
03/08/2018 |
HeberNasvac® Phase IV in Chronic Hepatitis B |
CIGB |
Registered outdated |
|
02/08/2018 |
NeuroEPO in stroke |
CIM |
Registered |
|
01/08/2018 |
Oncoxin-Viusid / Pancreatic adenocarcinoma / Adults / Phase II |
CATALYSIS |
Registered outdated |
|
10/07/2018 |
A Study of the Efficacy and Safety of Atezolizumab Plus Chemotherapy for Patients With Early Relapsing Recurrent Triple-Negative Breast Cancer. |
ROCHE |
Registered outdated |
